Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000096:biosynthesis; D001485:Basement Membrane / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007678:Kidney Glomerulus / Q000276:immunology; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009393:Nephritis / Q000150:complications / Q000628:therapy; D009846:Oliguria / Q000209:etiology; D010951:Plasma Exchange; D006435:Renal Dialysis
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide